NCT05470127
Evaluation of the Performance of a Novel Prostate Biopsy System Compared With Standard of Care Biopsy Needle on Quantitative and Qualitative Tissue Parameters
Recruiting
NAAges 18–90InterventionalDiagnosticUro-1 Medical
~200 participants
Updated 2025-05-07 on ClinicalTrials.gov
What's tested:Prostate biopsy needle
At a glance
Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Procedure Success
Measured over 1 Day of the procedure
+3 more outcomes measured
Conditions
Where it's being run
1 sites across 1 statesGeorgia1
Study leadership
- Thomas Lawson, PhD · STUDY_DIRECTOR · Lawson & Associates
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Adult male scheduled for prostate biopsy
Able to provide informed consent
Able and willing to provide verbal assessment of his condition 5 days post-procedure
Exclusion
Unwilling to provide consent
What this trial measures
- Procedure Success1 Day of the procedure
Percentage of tissue samples collected that are suitable for pathological review
- Core length of tissue in the sample1 Day of the procedure
Quantity of Tissue Samples Collected
- weight of tissue in the sample1 Day of the procedure
Quantity of Tissue Samples Collected
- Tissue Sample Preparation1 Day of the procedure
Time required to prepare the tissue samples for pathological review